yttrium radioisotopes has been researched along with B-Cell Chronic Lymphocytic Leukemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cassaday, RD; Flowers, ME; Gopal, AK; Green, DJ; Guthrie, KA; Maloney, DG; Pagel, JM; Press, OW; Rajendran, JG; Rezvani, AR; Sandmaier, BM; Sorror, ML; Storb, RF; Storer, BE | 1 |
| Khouri, IF | 1 |
| Ferrajoli, A; Jain, N; Keating, M; Lerner, S; O'Brien, S; Wierda, W; Wong, F | 1 |
| Leahy, MF; Turner, JH | 1 |
| Keating, MJ; Murray, JL; O'Brien, S; Tsimberidou, AM; Wierda, WG | 1 |
| Micallef, IN | 1 |
| Boland, C; Brown, MR; Carrasquillo, JA; Fleisher, TA; Foss, FM; Frincke, JM; Larson, SM; Lollo, CP; Mulshine, JL; Neumann, RD; Paik, CH; Perentesis, P; Raubitscheck, A; Reynolds, JC | 1 |
| Cheson, BD | 1 |
1 review(s) available for yttrium radioisotopes and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Ongoing trials with yttrium 90-labeled ibritumomab tiuxetan in patients with non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Radioimmunotherapy; Stem Cell Transplantation; Survival Analysis; Yttrium Radioisotopes | 2004 |
4 trial(s) available for yttrium radioisotopes and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD20; Chronic Disease; Cohort Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Myeloablative Agonists; Radioimmunotherapy; Survival Analysis; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Yttrium Radioisotopes | 2015 |
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.
Topics: Aged; Antibodies, Monoclonal; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Radioimmunotherapy; Remission Induction; Thrombocytopenia; Yttrium Radioisotopes | 2009 |
Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Clinical Trials, Phase II as Topic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Rituximab; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
Topics: Adult; Antibodies, Monoclonal; CD5 Antigens; Humans; Immunoconjugates; Indium Radioisotopes; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Subsets; Lymphoma, T-Cell, Cutaneous; Middle Aged; Radioimmunotherapy; Tissue Distribution; Treatment Outcome; Yttrium Radioisotopes | 1998 |
3 other study(ies) available for yttrium radioisotopes and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Radioimmunotherapy in allogeneic nonmyeloablative conditioning for B cell lymphoma: should we use it more often?
Topics: Antibodies, Monoclonal; Antigens, CD20; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Radioimmunotherapy; Survival Analysis; Transplantation Conditioning; Yttrium Radioisotopes | 2015 |
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Radioimmunotherapy; Retrospective Studies; Syndrome; Treatment Outcome; Yttrium Radioisotopes | 2004 |
Clinical trials referral resource. NCI-Navy: T-cell lymphoma or chronic lymphocyte leukemia.
Topics: Antibodies, Monoclonal; Clinical Trials as Topic; Humans; Indium Radioisotopes; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, T-Cell; Skin Neoplasms; Yttrium Radioisotopes | 1990 |